Company Profile

Terra Via (AKA: Solazyme Inc)
Profile last edited on: 10/22/2023      CAGE: 483L8      UEI: LNPGR84YHWD5

Business Identifier: Synthetic biology company converting algal biomass into biofuels for the transportation, cosmetic and food industries
Year Founded
2003
First Award
2006
Latest Award
2006
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

225 Gateway Boulevard
South San Francisco, CA 94080
   (650) 780-4777
   partnering@solazyme.com
   www.terravia.com
Location: Single
Congr. District: 15
County: San Mateo

Public Profile

IIn September 2017, all assets of Terra Via were acquired in an all cash deal by by Corbion - in the business of lactic acid, lactic acid derivatives, and lactides. In August 2017 Terra Via management - fiormerly doing business as Solazyme, Inc. - had published an anouncement that the firm had entered into agreement for the sale of substantially all Its assets subject to competitive bidding process. The firm also filed for Voluntary Chapter 11 Petitions to Facilitate Sale Process with a Commitment for DIP Financing to Support Ongoing Operations. TerraVia is/had been a plant-based food, nutrition and specialty ingredients company that harnesses the power of algae - descrribes as the mother of all plants and earth's original superfood. With a portfolio of breakthrough ingredients and manufacturing, TerraVia is well positioned to help meet the growing need of consumer packaged goods and established and emerging food manufacturers to improve the nutritional profile of foods without sacrificing taste, and to develop select consumer brands. TerraVia also manufactures a range of specialty personal care ingredients for key strategic partners. Headquartered in South San Francisco, TerraVia's mission is to create products that are truly better for people and better for the planet.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
150-249
Revenue Range
15M-20M
VC funded?
Yes
Public/Private
Publicly Traded
Stock Info
NASDAQ : SZYM
IP Holdings
150-249

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2006 1 NIH $99,937
Project Title: Recombinant system for ultra-large scale biomanufacturing of therapeutic proteins

Key People / Management

  Harrison F Dillon -- CEO and Founder

  Jonathan S Wolfson -- President and CO and C0-founder

  Adrain Galvez -- VP Process & Development

  Arthur Grossman -- Chief of Genetics

  David Isaacs -- Senior Vice President of Government Relations

  Tyler Painter -- Chief Financial Officer

  Juergen E Polle